Zivo Bioscience Inc (QB) (ZIVO) 시세

UPDATE: Reality of this week...

Nice gobble at 19.50 per share

Bid support strengthens....

I think we can all agree investor relations at Zivo is terrible. Stop wasting money and get rid of them.

Here is Microcap conference powerpoint from ZIVO's website. More in the poor communications dept.

https://d1io3yog0oux5.cloudfront.net/_693ef9cd8614ac34d26b455b76331834/zivobioscience/db/300/1570/pdf/Microcap+2025+Presentation.pdf

Amigo Mike

Gunner,

Honestly I take ZIVO at it's word regarding your quote. Payne clearly is very conservative about what he releases publicly. So "whatever happened to this idea" ..... it should be in motion right now. Tis why I think the action in the stock should be better and frankly still think it should already be above $25.

So at face value ..... we mushrooms should be thinking that ZIVO may be in receipt of a formal licensing offer from a global animal health company by now ... given that tomorrow is the end of January. Whether ZIVO is required to inform investors of receiving a licensing offer ..... I don't think they are obligated to share that unless potentially a specific letter of intent is agreed upon and signed which I think would get PR'd. And unfortunately an LOI is nothing more than 2 companies agreeing to discuss it ... it isn't binding. They of course WOULD be obligated to share if an agreement for a license is actually signed.

But my thinking here is .... lawyers ..... let's say ZIVO does have a licensing offer in hand right now from 1 .. or even more global animal health companies. If more than 1 involved if I am Payne I am not going to take first offer to hit the table. I'm going to play all angles. I don't know if ZIVO has engaged any experts to evaluate the value of a license for poultry and what an appropriate offer should be. Dunno if license request would be for more than poultry as there are closely related species and others that I'm sure are easy to test .... would it be territorial ...... what restrictions if any. My point being ...... I seriously doubt a license deal is offered and signed instantly. Lawyers, fine print, scope, valuation, who pays for what, who gets what .... etc etc etc ...... has to be gone over with fine tooth comb and of course both parties need to come to an agreement. So what I'm getting at is how prepared is ZIVO in understanding what the value of the license is and how long does it take lawyers to fiddle with the language and agree to terms ??? Notice ZIVO said expects to enter formal "negotiations" in January and finalize by EOQ.

So we wait !
Amigo Mike

Expects to enter into formal negotiations with a global animal health company in January 2025 and to finalize an agreement in the first quarter of 2025

Wonder what happened to this idea !!??

Gwinner,

Some bid support remains but doesn't appear to be in any hurry to do anything. And seller backed up a bit ... but still reasonably close on the offer.

As noted the warrants went silent ... but today .... over 43K traded so far. Not sure what to make of that action.
ZIVO about to present in next few minutes at Microcap conference.

Unfortunately I don't have the same positive vibes you do with regard owning the stock and "on the forefront of getting picked up nationally and potentially globally".
There still nobody interested in this stock other than the long time core of investors ....

Does ZIVO get some attention soon ? Dunno ......... I'd sure like to see it. Certainly would like to see PR closing a license with major animal pharma. And certainly would like to see ZIVO associated with avian flu .......... but ........ it's wait and see

Amigo Mike

I liked the BID support today too...hopefully it continues...
However, I have never been so deeply invested into a company that is on the precipice of being in the right spot at the right time. Poultry/Avian all on the news everyday now and ZIVO has been on the forefront of getting picked up nationally and potentially globally. In a racing pole position ZIVO is parked in the right spot.

I would suspect BID support will grow as word gets out about ZIVO. The investor presentations they plan on doing tomorrow will only help spread the word. However, the word just needs to land in the right hands...

Seems we are opening the day with a little bit of interest on the bid in the high $18s this morning ..... a small departure from the recent lower bids and no size being displayed on the offer. Is this the beginning of change in tone ? No one selling into it this morning.

We are reaching the end of January here ..... other than attending Microcap conference and presenting tomorrow afternoon .... some funding news via SEC reporting, not much to speak of. Looks alot like ZIVO spent 4th qtr cleaning it's financial house and setting things in order. They got rid of a small convertible with long time shareholder that used to be huge supporter. In the process of buying out incredibly awful co development participation agreements that partly underscore why Dahl had to go. These were incredibly bad ... last resort financing deals a few years ago .... that would have resulted in ZIVO paying out rouhgly 44% of revenues from licenses to those investors ..... meaning not able to use that revenue to advance business needs.

IMO ZIVO still isn't moving fast enough there and still isn't getting the name out there with what they are doing. I still think $18 is too cheap for where the company supposedly stands ... i.e. on the verge of a license for coccidiosis in chickens with a major animal pharma. But obviously that's just my opinion. Still haven't reached what had been the historical valuation of this company and its further along than ever.

I'd be surprised if the microcap conference stirs any buying. Action in the warrants has disappeared. Myself and everyone else in wait and see mode. I have been considering purchasing some shares .... but have not purchased or sold anything still. My now long term swing is sitting there staring me in the face daily asking me what I'm doing next LOL. Now stagnant for several weeks here. Have basically had too many other swing trade opportunities in other stocks so that's mainly why I have not stepped to the buy window here plus the cost of the trade was recovered long ago as posted here. So riding free.

Gut health and inflammation on the Today Show this AM. LOL

My ZIVO wishlist:
1. Close license for coccidiosis in broiler chickens
1a. Whomever that is ... I'd like to see purchase of stock as part of the deal
2. Quite honestly I'd like to see license or some sort of agreement for the development of coccidiosis candidate for additional verticals (turkey, swine)
3 Get on the stick and bring next round of testing on avian flu. First test was for LPAI ..... I'd like to see something on HPAI. And given the initial results it seems like it is more about tweaking options
4. Funding funding funding ..... for the last year+ basically been insider funding for the most part. See 1a above. Avian Flu is HOT. There are millions and millions of dollars out there being more of less tossed away on non solutions at both state and federal level. ZIVO might just have something that supports and solution ....... they need to find a way to get some of these gov't grants. Unfortunately this is something I think takes a while and I don't think there is a "fast track" path to any of this type money ...... but ZIVO needs to be in the game and making noise here.
5. Sell the company ... I'll take $100+ a share (even though I think it is worth much more). ZIVO given its corporate structure is ripe for sale. A big detractor in my book .... there is no apparent succession plan for Payne. I believe he's in his late 70s. An he's old school. Need to understand the plan and badly needs visibility. Today's electronic age .... ZIVO isn't in the game at all but may have what we all think is a discovery in the inflammation space .... cause that is what all this is rooted in. And I just don't see how this company develops additional verticals and grows without long term leadership. I just don't see years and years more of testing and development of new verticals of which IMO ... there are numerous opportunities with ZIVO's product candidate.

Tic tok .....tic tok ....
Amigo Mike

Looks like ZIVO is presenting at 2:30 PM on Thursday this week.

https://themicrocapconference.com/presentation-schedule/
Not the most ideal presentation time. Still scratching my head a bit regarding why doing this conference and Payne was not good at the last recorded conference.. Also does not appear like there is an option to listen to the conference presentations which doesn't help current investors much. These conferences are usually intended to stir up PP money. If they are discussing license with 1 or more major animal pharmas they should simply be asking them to buy some stock as part of the deal. It's petty cash to them. Don't need scumbag IBs in it. Get a license for coccidosis done and move ahead on avian flu should put stock price back on track towards $25 (and should be higher than that) and additional money can come from warrants that expire in a couple months.

Would be nice if ZIVO had news this week in front of that conference. Something fresh to talk about and get an investor interested.
Amigo Mike

Nice BID support at 17.60 (1,288 shares currently) would like to see that work its way higher throughout the day...
MicroCap Conference is needed...just need to keep spreading the news. Actually i wish they would do 2-3 per month at a minimum

Same as it always was. They cannot execute. No one is putting serious money in this if they cannot pull in revenue. The golden Rolodex is more like fool’s gold.

Just seems to me if they have to keep going to these conferences, looking for investors, no one is interested. What am I missing ?

ZIVO Bioscience to Present at The Microcap Conference 2025
Download as PDFJan 22, 2025
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)-- Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J.

Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy, and investment opportunities.

Event: The Microcap Conference 2025
Location: Studio 1, Borgata Hotel Casino & Spa
Date: Thursday January 30, 2025
Time: 2:30 PM Eastern Time

Investors interested in meeting with management can register for the conference here.

About ZIVO Bioscience

Zivo Bioscience, Inc. is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.


View source version on businesswire.com: https://www.businesswire.com/news/home/20250122415215/en/

ZIVO Bioscience
Keith Marchiando, Chief Financial Officer
(248) 452-9866 x130
kmarchiando@zivobioscience.com

Alliance Advisors IR
Tirth T. Patel
(212) 201-6614
tpatel@allianceadvisors.com

Source: Zivo Bioscience, Inc.
Released January 22, 2025

Yesterday trading was a bit odd...We had good Bid support but conversely we had a Seller just dropping sells at the Bid. And today we got nothing lol

Zivo executives- get to work! Take the lead from Trump and stop dawdling. You have a pro-business administration sympathetic to natural therapies rather than mRNA Frankenstein drugs. Stop playing financial engineering games and start signing agreements to bring in much needed revenue!

Regarding the 8K last evening,

I pulled the below information from the most recent 10Q surrounding the participation agreements with bold added for those who think everything is free. Participation Agreements

From April 13, 2020, through May 14, 2021, the Company entered into twenty-one License Co-Development Participation Agreements (the “Participation Agreements”) with certain accredited investors (“Participants”) for an aggregate of $2,985,000 in proceeds. The Participation Agreements provide for the issuance of warrants to such Participants and allows the Participants to participate in the fees (the “Fees”) from licensing or selling bioactive ingredients or molecules derived from ZIVO’s algae cultures. Specifically, ZIVO has agreed to provide to the Participants a 44.775% “Revenue Share” of all license fees generated by ZIVO from any licensee.

The Participation Agreements allow the Company the option to buy back the right, title and interest in the Revenue Share for an amount equal to the amount funded plus a forty percent (40%) premium, if the option is exercised less than 18 months following execution, and for either forty (40%) or fifty percent (50%) if the option is exercised more than 18 months following execution. Pursuant to the terms of twelve of the Participation Agreements, the Company may not exercise its option until it has paid the Participants a revenue share equal to a minimum of thirty percent (30%) of the amount such Participant’s total payment amount. Pursuant to the terms of the one of the Participation Agreements, the Company may not exercise its option until it has paid the Participant a revenue share equal to a minimum of one hundred forty percent (140%) of the amount such Participant’s total payment amount. Five of the Participation Agreements have no minimum threshold payment. Once this minimum threshold is met, the Company may exercise its option by delivering written notice to a Participant of its intent to exercise the option, along with repayment terms of the amount funded, which may be paid, in the Company’s sole discretion, in one lump sum or in four (4) equal quarterly payments. If the Company does not make such quarterly payments timely for any quarter, then the Company shall pay the prorate Revenue Share amount, retroactive on the entire remaining balance owed, that would have been earned during such quarter until the default payments have been made and the payment schedule is no longer in default. So the participation agreements were entered into in lieu of the company receiving financing in the amount of $2.985 million. So shares issued to clear these agreements is part of the buyout/repayment ... and aren't "free" as some think. The investors funded nearly $3 million to ZIVO for these agreements and appear to be getting paid back to the investors in mostly stock.

From last night's 8K Effective January 9, 2025, the board of directors of Zivo Bioscience, Inc. (the “Company”) authorized the Company to enter into a series of Exchange Agreements (“Exchange Agreements”) with certain accredited investors (“Investors”) party to License and Co-Development Participation Agreements (“Participation Agreements”) with the Company. By way of background, between April 13, 2020 and May 14, 2021, the Company entered into a series of approximately twenty Participation Agreements with the Investors, pursuant to which, each Investor funded a portion of the Company’s budget toward development of a license in return for a revenue share and warrants. Under the Participation Agreements, the Company had a buy-out option pursuant to which it could purchase the Investors’ right, title and interest in the revenue share for an aggregate minimum purchase price of $5,306,500. The Exchange Agreements would provide for the cancellation of the Purchase Agreements and accompanying forfeiture of each Investor’s right to earn certain cash from the revenue share and buy-out option in exchange for 212,260 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), in the aggregate (the “Exchange Program”). To date, the Company has completed an exchange with two Investors for a total of 14,200 shares of Common Stock of the Company.

The Exchange Agreements also contain a release of claims and standard representations and warranties of both the Company and each Investor. Laith Yaldoo, a director of the Company, manages, directs, and controls two entities that are expected to participate in the Exchange Program as Investors. So Dahl bent ZIVO over the barrel for nearly $3 million in funds and due to the buyback clauses looks like the cost to buy them out is $5.3 million (Dahl .. the gift the keeps on giving) for which it appears 212,260 shares will be issued to the investors to settle these agreements and rid the company of them.

So face value the investors funded roughly $3 million ... and would seemingly be getting 212,260 shares as part of exchange agreement .... which would give the shares an average basis of just over $14/share at face value. But the 8K sez the buyout is for $5.3 million present value which would mean the share basis is around $25/share but that seems a bit strange. That would be agreeing to taking stock at above market value. The fact they are taking stock at all would indicate to me they see light at the end of the rainbow and higher stock prices ahead. More confidence. This does represent some minor dilution but super strong hands and those shares would never see the market assuming Strome and Yaldoo own most of those agreements.

So far I am leaning towards net positive.
-We have minor dilution to get out of a simply awful financing agreement that would see ZIVO paying out over 44% of it's revenues from licensing deals (a serious ouch)
-Presumably most of those shares go to insider iron fist hands and never see the market.
-ZIVO more cleaning of bad deals and this one was especially bad.
-Seemingly "prepping" for something coming down the pike and making sure all the revenue stays with ZIVO.

Amigo Mike

If you are referring to last night's 8K ..... your statement is wrong i.e "free shares" .... as usual.

Amigo Mike

Look at the latest 8k. A board member insider getting more free shares. Shocking.

8K filed after market close today.

Still digesting but it appears this is another cleanup item (another old bad financing back in the Dahl days). This might have been one of the items that led me to stop talking to Dahl altogether years ago ..... as i did talk to him at shareholder meeting and occasionally on the phone to figure out WTH he was doing. This was also likey when I amped up the call for Dahl getting kicked as CEO.

This has to do with awful last resort revenue participation agreements several years ago in exchange for immediate financing. I'd have to go back and look but if I remember correct Dahl gave up something on the order of 40+ % of ZIVOs future revenues in exchange for financing to keep ZIVO going. I can't remember how long the revenue participation lasted but it was far longer than it should have been. And as 8k sez there was a ZIVO buyout option which it appears they are exercising in exchange for stock. With the initial numbers looking like the exchange is for a price much higher than current market price. Gotta read it closer.

https://ir.zivobioscience.com/sec-filings-email/content/0001654954-25-000453/zivo_8k.htm

I'll have to go back and find those agreements. I'm 99% sure that Strome and Yaldoo own most of those.

Amigo Mike

Gwinner,

You sound like you are assuming ZIVO wants to sell. IMO .... I don't think that is the case.

Investment bankers are whores. Just take a look at the financings ZIVO did while on Nasdaq. RIPOFFS. Of course ZIVO's failure to deliver anything of substance played a major role in that. And that's partly why ZIVO and we were RIPPED OFF. So were I CEO and wasn't exploring a sale .... I wouldn't engage an IB unless I was presented an offer from someone. It isn't simple and costs money.

If you are talking just about licensing, don't need an IB for that. Payne has the golden rolodex and can handle that.

Looks like we have seller coming into the market in the last couple minutes today and dumping the stock. Oh well .... I know it is tough to stand pat and watch pain dry ..... but not sure why anyone would be selling here in lieu of recent news. License on coccidiosis could be announced any day here. Will it ... unlikely ... but one never knows. Sounds like ZIVO 'may' have an auction potential on the license with more than 1 animal pharma apparently in play.

I do think ZIVO does need to come back with more news on license and bird flu ..... cause the timing of those releases sucked. But if there isn't more information, I'm sure a rerelease of news will be taken negatively as is always the case here.

Amigo Mike

Not sure if you guys saw CNBC this morning.... big BIG BANKS killed it with earnings....Do you know what the bulk of the earnings came from from?? INVESTMENT BANKING was a huge driver...which simply means ZIVO wants a partner, acquirer, strategic investor and those investment bankers get PAID to put deals together.

I've said this before on this board. ZIVO needs an investment banker to find a proper suitor...Wall Street is filled with cash and looking to park it anywhere. They just need to believe a little to formulate a forecasted model that is scalable....It really is a simply thing for ZIVO to do...

Gwinner,

Also just wanted to point out that if you are just thinking about "money" for ZIVO, additional monies could be on the horizon near term. By near term let's call it 1st half of 2025.

1. Obviously Strome bought $1.5 million in stock
2. 1st qtr - Coccidiosis license deal. It is of course unknown what this license would garner and how much coverage (territory) it will cover.

My opinion is the upfront money isn't likely to be significant because the product candidate still has to go through USDA approval process which ZIVO has not outlined specifically what that looks like. But license likely also has milestone payments as each regulatory hurdle is passed. Royalties on commericial sales of course.

As part of the coccidiosis license I would very much like to see the partner buy anywhere for 100,000 to 250,000 shares of ZIVO. Skin in the game, incentive to perform ..... and commercial success means they win too.

3. I dunno what ZIVO is doing in this lane but GRANTS GRANTS GRANTS. Federal and state. At this point, I don't believe there is any excuse not to be requesting money from whatever govt agency is handing out grants for algae development, non antibiotic option in the food supply, avian flu specifically and anything else you can think of. (mastitis in dairy cows). You name it.

The state of Michigan is ZIVO's home state of residence. They've reported bird flu outbreaks. They be first up on my list. LOL ,,, in the get involved lane I had already gone down the path of finding the Dept of Agriculture contacts for State Of Michigan. I didn't do anything about it but I took a look. =) In past years ZIVO also took part in local technology and business innovation gatherings. Haven't seen that for a while so doubt they are doing anything in that lane these days.

The incoming federal administration .... and RFK .... certainly appear to be open to alternatives to the norm. No idea what kinda contacts Payne has at that type of level but somebody should be on it.

4. There is the little matter of one of the last "rip off" financings that ZIVO did before dropping from NASDAQ that involved Armistice Capital hedge fund. I've brought these guys up before. They have 2 year warrants on ZIVO that is already part of the fully diluted count for the stock. Roughly 250,000 shares at $16.80. And I think they expire somewhere around June. I'd have to go look.

I am not a securities expert or securities lawyer .... but the warrant language leads me to believe the only option for exercise of these warrants is exercising them with cash if ZIVO has filed a proper registration statement covering the shares underlying the warrants. If my research is correct, that already happened. So Armistice exercise for cash would provide $4.2 million. I have prior outlined that Armistice could breath on ZIVO and run it to $50 without batting an eye. They would stand to make a substantial amount of money were that to happen.

So I think there are multiple avenues for money near term ... some or all could happen at any time IMO.
Amigo Mike

Gwinner,

IMO on the $1.5 million (at $20.19 to reiterate for some that don't get it),

-Funds the 1st qtr ... that's it. Presumably stop gap to license.
-Nasdaq ... ah ... no. It isn't a waste of time but $1.5 million isn't enough in the first place to support uplisting. And there are restrictions to raising money and other things if moved to Nasdaq. More costs as well. Would rather see laser focused on coccidiosis license .... and depending on what that looks like could further support the potential for Nasdaq.
-What algae ponds/product are you referencing ? For ZIVOLife ? That's in Peru and been no update on that for far too long. Plenty of space there to add ponds if needed but if you are talking product supporting the coccidiosis license ...... ZIVO hasn't been very clear on how that is actually produced .... but my opinion is that is produced via different methodology that ZIVO hasn't discussed or articulated in any of the coccidiosis PRs. This is also something I think that ZIVO should bring to the forefront with investors as well cause I don't think it is understood well ... or ... even at all. Hell I might not even understand it ... LOL.
-Avian flu advancement ... ABSOLUTELY.

Amigo Mike

Question? With ZIVO receiving a fresh $1,500,000+ from Strome what do you think they do with the cash? Do they move back to NASDAQ? Or is that waste at this time? Do they get started with some algae ponds/product etc? Do they advance further testing their proprietary active ingredients for Avian Flu? Or do they use the money to keep the lights on for another 6 months or so?

Gwinner,

Appreciate the note. I do what i can here. Not sure really how many follow this board. I do know there are a handful of lurkers who rarely or don't post at all. But overall there are not many here in the larger scheme of things. I do really hope that at least some folks have benefitted from how weasel and I trade this thing over the years. Very few boards have folks that openly share buy/sell activity in real time.

ZIVO has had a seller since we've reached this $20 area as evidenced by the flat action here going back a ways now. I get it but had hoped the latest round of news might put a pause on that. But at same time .... the warrant action leads me to think someone is rotating a common position into warrants. Makes sense from a leverage perspective to take money off the table in the common, pocket some cash but buy warrants to add leverage if you think the stock takes off again. The warrants have roughly 16 more months on them. Anyway the sellers have been getting soaked up slowly. Anyone's guess whether it continues.

MRNA .... LOL .... ZIVO probably better for covid too. But I suppose we may never know on that.

Personally I expect $50 in 2025. At minimum.
Amigo Mike

Looks like we got a New Year seller...

Nice post Gwinner

Weazel/Amigo -
My point to this is we/you guys are already doing alot of the PR'ing for ZIVO right here on this Board. And, you guys have done a fantastic job providing insight and digging into each phrase or nugget of info that sparsely comes our way. You guys mind wrap the data and put it out on this board in way where the laymen (such as myself) grasps it.

Moderna Stock Soars After First US Bird-Flu Death (Jan 7 Investopedia)

That above headline should start with ZIVO - Our voice needs to land on a Moderna board so other share holders (Not Pumping here) understand that a company called ZIVO BIOSCIENCE is all about Poultry health...and just maybe...just maybe the word can get moving to a main stream stage...

I do appreciate everyone's insights that have been posted over the years. We sometimes might disagree on things but thats okay...we are in it to win it...!

Strome seems to be the most sophisticated insider when it comes to profiting from investments in public companies. I would like to see him putting pressure on the board and showing them how to move at a faster pace. Also get results out of the investor relations contractors or end the agreement. Holding one small investor relations event with Florida retirees in six months is a joke.

Gwinner,

I agree with Weasel ..... tis not really our job to spread the word.

I think this is a billion dollar company ... with a "B" ...... but its up to mgmt to deliver .... I don't work for ZIVO. I am an owner of ZIVO and vote my shares accordingly. Unfortunate that the public company environment isn't set up differently that a smaller shareholder can't push change but that is what you sign up for buying public company shares.

"ZIVO products have been proven" .... that may be true ..... but the bottomline is revenues and profits ..... and that's a resounding zero.

So we are all buying into the future prospects. I take Payne at face value ... frankly surprised he PR'd talking to multiple animal pharmas but I expect a coccidiosis license in the 1st qtr here. He appears to me to be excessively conservative when it comes to releasing information so I think for him to say this means he's pretty confident. Not to mention a $1.5 million insider buy at more or less the highs ..... a week later. Money talks .... you know the rest .....

Amigo Mike

Tony, you can be angry at management for there past mistakes...I/we get that...BUT, they are onto something here with there proprietary active ingredient that could reduce the transmission of the Avian Flu...We need to help spread this news...obviously this task should fall on someone else but in the meantime we need to be shouting this break-through and posting and talking to whoever will listen. This is something that is only to get worse before it gets better...ZIVO products have been proven.

Nah...nah...nah...nahhhhhhhhhhhh

You see, Gwinner...anything outside of the company themselves "spreading the news" via LEGITIMATE PR's and/or Licensing deals...ANYBODY ELSE "spreading the news" is called a stock PUMP. PERIOD.

I don't care how many tests that are "good", "likely to result in anything", how much you believe in the info, how much it fits the current national narrative, et al.

When those outside the company "spread the news" without ACTUAL information from the company that has resulted in ACTUAL business transactions...it's all hypothetical...and this is called a PUMP.

Understand, this DOES NOT mean I'm saying you cannot have your opinion of where the company is, that they are on the right path, etc. Of course that's the case. I'm referring specifically to the "spread the news" bit...

So, Tony is correct...the COMPANY needs to deliver. Not the shareholders...

PS- and yes, I know the company released info on a test regarding Avian Flu. That hasn't amounted to anything yet...so, it still applies.

Tony, you can be angry at management for there past mistakes...I/we get that...BUT, they are onto something here with there proprietary active ingredient that could reduce the transmission of the Avian Flu...We need to help spread this news...obviously this task should fall on someone else but in the meantime we need to be shouting this break-through and posting and talking to whoever will listen. This is something that is only to get worse before it gets better...ZIVO products have been proven.

Zivo blew opportunities during the pandemic to find a partner with funding to quickly develop a therapeutic. Didn’t they learn their lesson? We were told during the last test it was funded by a partner and agreements would be signed pending results. Results were positive and we are going on how many months now with no agreement? Now we are told end of March before we might see a licensing agreement , but limited information released. Sell the company or find a partner with money NOW.

Oh look, more free shares for insiders. What is Cornell’s average price per share?

Late SEC Form 4 filings this evening after market close.

Yaldoo, Maggiore, Cornell and Masterson ...... between 8500 and 11000 shares each give or take a few ..... no explanation on the form 4s and no prices.
Looks to me likely BoD grants for 2024

Amigo Mike

Gwinner,

I am seeing that H5N1 is a subset of Influenza A (ie. the flu) testing. And you can take an influenza A rapid test to see if you have indications ...... but need further specific testing to H5N1 to see if that is avian flu specifically. Wondering if ZIVO has therapeutic for supporting the flu that is starting to get major attention in addition to avian flu. LOL. Ya take the rapid flu test to support not only your own indication .... but to support staying away from friends and family to prevent transmission if it is positive. =)

Anyway ... some California grocery stores are without eggs .... North Carolina ..... etc etc etc. Getting bigger.

Can ZIVO move fast enough ??? Is one of the major animal pharmas they are talking to getting itchy yet ? I still don't know what major animal pharma would just buy ZIVO out. The tests have been positive forever.

SHOW ME THE MONEY !!!

Amigo Mike

Hey Weasel,

Good to hear from ya. I think ZIVO will be fine. I do however think the overall market is going to take a hit and dump in the new year.

Personally I am looking at the buy side of ZIVO at this point. So if Mr Market wants to give me a discount I'll take it. =)

I think ZIVO has plenty of good news to come this year and I think $20 won't be the end of it.

Amigo Mike

Mike- do not be surprised if we actually see the "opposite" of what we typically see this time of year. Specifically, we did not get the standard end of year tax loss selling that we've all grown accustomed to around here...as there were no losses (HOORAY! This may be a first for ZIVO???).

HOWEVER, I suspect we might see some profit taking early next year by folks who wanted to delay their capital gains tax by another year. This is not just a ZIVO thing fwiw, I actually think we could see some of this happening market wide in the high flyers. We'll see.

Perhaps 2025 is the year this thing finally spreads its wings...

Happy New Year!

Another block of stock showed up on the offer in the last 1/2 hour.

2,666 at $21.69 above the market. Not large but .... relatively speaking .... big for the volume.

Oh well .... to each his own. I would expect that eventually gets absorbed as well.
ZIVO been consolidating since mid October and absorbing all sellers.

Amigo Mike

Gwinner,

That can't be correct. Tony said ZIVO was being mum and wasn't providing any info or getting anything done so that insiders could buy on the cheap. The lack of communication from Zivo has this down to $15. Look for a private placement with insiders at this level or below before any news released that will bring back above $20. Ooops . You'll also notice no response from Tony on how PP price is determined.

Gee .... very large buy ABOVE $20. Wonder if more will be posted. Totaling $1.5 million. It wouldn't shock me to see BoD members post buys as well.

IMO ... insider buying at $20 IS HUGELY POSITIVE given where this company is today. And this stock isn't going to see the market any time soon or if at all.

Amigo Mike

Love seeing this...he bought the shares a lil over $20.00

Zivo Bioscience Insider Bought Shares Worth $1,514,250, According to a Recent SEC Filing
6:51 AM ET 12/31/24 | MT Newswires
Zivo Bioscience Insider Bought Shares Worth $1,514,250, According to a Recent SEC Filing
06:51 AM EST, 12/31/2024 (MT Newswires) -- Mark E Strome, 10% Owner, on January 03, 2024, executed a purchase for 75,000 shares in Zivo Bioscience (ZIVO) for $1,514,250. Following the Form 4 filing with the SEC, Strome has control over a total of 398,683 shares of the company, with 398,683 controlled indirectly.

This is news story in Michigan just in the last hour or so.

https://www.fox2detroit.com/news/bird-flu-outbreak-grows-michigan-three-more-sites-exposed-virus

ZIVO should absolutely be in touch with Michigan's Dept of Agriculture.

Amigo Mike

Kinda why I said ZIVO should have someone in the office spamming the depth of agriculture in every state ... including Michigan as home state. Plus da Federal Dept of Agriculture, HHS, CDC, you name it.

Any news publication writing about it. Any industry publication.

Any activist that advocates non antibiotic options in the food supply.

It is a no trainer. IMO ZIVO should come back with more info on the tests as well. But of course that is just me. They aren't doing it cause Tony said they still wanna buy on the cheap. ROFLMAO !

Of course how do we know ZIVO isn't doing any of these things ?? We don't.

Amigo Mike

Countless Bird Flu articles over the weekend....notably the Bird Flu virus likely mutated to a human...egg prices soaring again...they go on and on.

ZIVO please get this info to the highest level of government. Emergency money for implantation is available...

Pathetic how no work is being done by Zivo investor relations to promote the latest bird flu results. They release the information on the Friday before Christmas with zero social media promotion. How can anyone defend this and why do the shareholders with significant holdings who also control the board tolerate it? The only justification is they legally need to release the information but do not want the stock to increase so they can pick up more shares.

LOL,

38K shares of buying on the common in a single day would prolly push this thing past $25 and maybe close to $30. I'd be happy to see that over a week. That's 1%+ of the stock outstanding. Think about that eh ? And the float .... IMO the float is less than 1 million shares.

Somebody still selling stock but it is getting soaked up still which is a very good sign. It has felt like selling in the common to buy warrants but at same time the common isn't pulling back with any significance. Granted overall there isn't alot of volume in the common but appears like it's getting scooped again ..... but in a stealthy manner.

Are the sellers at $20 still smart ?? LOL ... i don't think so..... but that's JMHO. With the news on avian flu ... and ZIVO now acknowledging for investors they are now talking to more than 1 major animal pharma .... I'm a bit perplexed by any selling but folks gotta do what is best for them.

Hell I am contemplating new buys here on ZIVO but have a couple other plays that are on fire and want to let them play before I drop anything on ZiVO. But I am leaning towards buy side here.

Amigo Mike

Yeah, I'd like to see a 38,000 + share trade day on the common soon

More size action on the warrants again.

Geez someone really going to town on these the last several weeks.

Amigo Mike